Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

3 Under-the-Radar Tech Stocks to Buy in 2023: https://g.foolcdn.com/editorial/images/747257/bearded-person-at-desk-by-computer-taking-notes.jpg
3 Under-the-Radar Tech Stocks to Buy in 2023

Even though there are hundreds of tech stocks on the market, most of Wall Street's attention tends to be focused on just a few of the biggest industry players. That's unfortunate because there are

Why Nexstar Media Stock Rose 15.2% This Week: https://g.foolcdn.com/editorial/images/747844/couple-on-couch-watching-news-on-tv.jpg
Why Nexstar Media Stock Rose 15.2% This Week

As of Friday at 2:30 p.m. ET, Nexstar Media Group's (NASDAQ: NXST) stock price had gained 15.2% this week, according to S&P Global Market Intelligence. The stock had been up as much as 19.1% during

Is Moderna Stock a Top Buy?: https://g.foolcdn.com/editorial/images/747633/growth.jpg
Is Moderna Stock a Top Buy?

Biotechnology stocks have the potential to deliver outstanding returns for investors. Indeed, some of the best-performing stocks in the past two decades have emerged from the biotech industry.

2 Top Biotech Stocks Defying the Bear Market: https://g.foolcdn.com/editorial/images/747410/cancer-patient-flexing-muscle.jpg
2 Top Biotech Stocks Defying the Bear Market

Last year was challenging for the stock market. Things have been better since 2023 started, but some equities have even performed pretty well throughout this ordeal. That's the case with Exelixis

1 Major Advantage That Sets Roku Apart From Netflix and Other Streamers: https://g.foolcdn.com/editorial/images/747356/college-students-young-adults-millennials-using-laptop-outside.jpg
1 Major Advantage That Sets Roku Apart From Netflix and Other Streamers

Streaming has become the norm for many TV viewers, but streaming companies are still duking it out for eyeballs and subscriptions. The lead position in consumer accounts mostly see-saws back and

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
This 1 Number May Completely Change Your Opinion About Moderna: https://g.foolcdn.com/editorial/images/747636/gettyimages-468679176.jpg
This 1 Number May Completely Change Your Opinion About Moderna

Moderna (NASDAQ: MRNA) stock soared during the pandemic as investors bet on the company's coronavirus vaccine candidate. Since then, the biotech launched a vaccine, followed by updated boosters, and

Why Semtech Stock Popped Today: https://g.foolcdn.com/editorial/images/747700/stock-chart-arrows-going-up-1.jpg
Why Semtech Stock Popped Today

Shares of Semtech (NASDAQ: SMTC) climbed as much as 10.2% early Thursday, then settled to trade up 7.5% as of 2:30 p.m. ET after the Internet of Things (IoT) systems and cloud connectivity services

Will Roku's Latest Cuts Help Make the Business Profitable?: https://g.foolcdn.com/editorial/images/747183/investor-looking-at-a-chart.jpg
Will Roku's Latest Cuts Help Make the Business Profitable?

Digital media company Roku (NASDAQ: ROKU) has been struggling with profitability in recent quarters. While the business has been growing thanks to the rising popularity of streaming services, the

Why COVID Vaccine Demand Might Not Be That Strong: https://g.foolcdn.com/editorial/images/747178/a-group-of-scientists-looking-at-a-report.jpg
Why COVID Vaccine Demand Might Not Be That Strong

As fall arrives, potential demand for COVID vaccines is becoming a big question mark  -- and how it plays out could have a big impact for companies like Novavax (NASDAQ: NVAX) and Moderna (NASDAQ:

Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks: https://g.foolcdn.com/editorial/images/747177/a-couple-counting-money.jpg
Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks

Inflation is giving investors more of an incentive to find ways to increase their income. If you have a decent nest egg saved up, you can use it to invest in dividend stocks to improve your

Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks: https://g.foolcdn.com/editorial/images/747177/a-couple-counting-money.jpg
Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks

Inflation is giving investors more of an incentive to find ways to increase their income. If you have a decent nest egg saved up, you can use it to invest in dividend stocks to improve your

2 Top Stocks to Buy Near Their 52-Week Lows: https://g.foolcdn.com/editorial/images/747086/pharmacist-talking-to-patient.jpg
2 Top Stocks to Buy Near Their 52-Week Lows

The market is putting up a strong performance this year with the S&P 500 gaining 16% as of this writing. That's a far cry from what we saw for most of 2022 when equities experienced a painful

Where Will Roku Stock Be in 3 Years?: https://g.foolcdn.com/editorial/images/747341/couple-enjoys-streaming-programming.jpg
Where Will Roku Stock Be in 3 Years?

Digital media player manufacturer and video streaming platform Roku (NASDAQ: ROKU) managed to build itself into the world's leading operating system for streaming TV around a popular ad platform

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
1 Growth Stock Down 77% You'll Regret Not Buying on the Dip: https://g.foolcdn.com/editorial/images/747425/growth-stock-down-77.png
1 Growth Stock Down 77% You'll Regret Not Buying on the Dip

Fool.com contributor Parkev Tatevosian evaluates Etsy (NASDAQ: ETSY) stock to explain why he thinks it's a bargain at current valuations.

*Stock prices used were the afternoon prices of Sept. 10

CTS EVENTIM has launched the second construction phase of its new ARENA FOR MILAN in the Santa Giulia area – the most modern sports and live entertainment arena in Italy.: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23704/EVE_Logo.svg.png
CTS EVENTIM has launched the second construction phase of its new ARENA FOR MILAN in the Santa Giulia area – the most modern sports and live entertainment arena in Italy.
CTS EVENTIM has launched the second construction phase of its new ARENA FOR MILAN in the Santa Giulia area – the most modern sports and live entertainment arena in Italy.
EQS-News: FUCHS opens new, state-of-the-art plant  in Ba Ria-Vung Tau, Vietnam: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23712/240px-Fuchs-Petrolub-AG-Logo.svg.png
EQS-News: FUCHS opens new, state-of-the-art plant in Ba Ria-Vung Tau, Vietnam
EQS-News: FUCHS opens new, state-of-the-art plant in Ba Ria-Vung Tau, Vietnam
EQS-News: ENCAVIS investment in TokWise: Joint development of AI-powered Software-as-a-Service (SaaS) to optimise electricity sales: https://upload.wikimedia.org/wikipedia/commons/thumb/4/44/Encavis_logo.svg/1024px-Encavis_logo.svg.png
EQS-News: ENCAVIS investment in TokWise: Joint development of AI-powered Software-as-a-Service (SaaS) to optimise electricity sales
EQS-News: ENCAVIS investment in TokWise: Joint development of AI-powered Software-as-a-Service (SaaS) to optimise electricity sales
A Bull Market Could Be Here: 4 Reasons to Buy Mattel Stock: https://g.foolcdn.com/editorial/images/747082/organizing-toy-cars-in-basket.jpg
A Bull Market Could Be Here: 4 Reasons to Buy Mattel Stock

There's no denying that the macroeconomic backdrop could be healthier. Still, given lingering inflationary pressures, benchmark interest rates that are higher than they've been since 2007, and so-so

DocuSign Stock: Bear vs. Bull: https://g.foolcdn.com/editorial/images/747158/person-signing-tablet.jpg
DocuSign Stock: Bear vs. Bull

DocuSign (NASDAQ: DOCU) posted its latest earnings report on Sept. 7. For the second quarter of fiscal 2024, which ended on July 31, the e-signature leader's revenue rose 11% year over year to $688

Here's My Top Growth Stock to Buy in 2023: https://g.foolcdn.com/editorial/images/747439/tv-couch-fight.jpg
Here's My Top Growth Stock to Buy in 2023

I know we're more than halfway done with this year already. And the stock I'm about to recommend (again!) has already doubled its share price in 2023. Yet, it's not too late to invest in Roku

Albemarle Wants to Consolidate Lithium Production With a Key Acquisition -- Is the Stock a Buy?: https://g.foolcdn.com/editorial/images/747243/mining-construction-coal-dirt-industry.jpg
Albemarle Wants to Consolidate Lithium Production With a Key Acquisition -- Is the Stock a Buy?

Electric vehicle (EV) production is a top priority among automakers this year. However, for miners and refiners of lithium, a key raw ingredient in the manufacture of the big batteries needed in

Is DocuSign Stock a Buy Now?: https://g.foolcdn.com/editorial/images/747027/person-signing-an-e-signature-document.jpg
Is DocuSign Stock a Buy Now?

Among the work-from-home era stocks that rose and fell is DocuSign (NASDAQ: DOCU), the e-signature software company. Although the stock was stellar in 2020 and 2021, it has been atrocious since

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc